An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation.
about
Interoception and learning: import to understanding and treating diseases and psychopathologiesMDMA: a social drug in a social context.Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine useOptimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal.Anhedonia and the relative reward value of drug and nondrug reinforcers in cigarette smokers.Does Extended Pre Quit Bupropion Aid in Extinguishing Smoking Behavior?Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence.Improving efficiency of initial tests for efficacy in smoking cessation drug discovery.Withdrawal-Related Changes in Delay Discounting Predict Short-Term Smoking Abstinence.Validating Use of Internet-Submitted Carbon Monoxide Values by Video to Determine Quit Status.Self-control depletion and nicotine deprivation as precipitants of smoking cessation failure: A human laboratory model.Initial Cross-Over Test of a Positive Allosteric Modulator of Alpha-7 Nicotinic Receptors to Aid Cessation in Smokers with or Without Schizophrenia.The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio.
P2860
Q27013751-7ADBBB87-18D2-462E-B0D0-68E9B33E32B9Q27325091-BC6FA9BB-43B4-476F-A1D8-4C7D3DE090AEQ34315501-55A2D8C6-1D02-4732-ACFB-B8671FF2365DQ34870758-67E14286-5DBE-447A-AC45-B0347C82E694Q35543043-400E970B-629F-4645-8DC4-A34E209782BAQ36181354-D804AB0F-B8CA-46F0-90DB-0C97BA3F6E0EQ36939862-06FCDD7C-2203-4E5D-8EA9-8EA95BA3A56CQ38241372-BB6F005E-B8FC-4499-B198-19B55375962AQ38685937-D348A5EF-A20C-4558-8A41-5C1FC6402AC5Q38785942-DC3C6B7D-2A1D-431D-94C5-47378DB84C47Q45055476-FDBAB904-C814-4169-A129-B44B903EF198Q45074229-72BB0AB4-EF3F-4834-BBAE-CD6ACC6CAAC1Q48132081-610B7576-7A4C-44E3-A26B-9915B3C3A2E6
P2860
An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An efficient early phase 2 pro ...... efficacy in smoking cessation.
@en
An efficient early phase 2 pro ...... efficacy in smoking cessation.
@nl
type
label
An efficient early phase 2 pro ...... efficacy in smoking cessation.
@en
An efficient early phase 2 pro ...... efficacy in smoking cessation.
@nl
prefLabel
An efficient early phase 2 pro ...... efficacy in smoking cessation.
@en
An efficient early phase 2 pro ...... efficacy in smoking cessation.
@nl
P2860
P1433
P1476
An efficient early phase 2 pro ...... efficacy in smoking cessation.
@en
P2093
Kenneth A Perkins
P2860
P2888
P356
10.1007/S00213-013-3364-6
P50
P577
2013-12-03T00:00:00Z